Zhitong Finance App News, Quanxin Bio-B (02509.HK) issued an announcement. The board of directors believes that the company's current stock price seriously underestimates the company's value. With full confidence in the company's future development prospects and high recognition of the company's intrinsic value, in order to continuously enhance market confidence in the company and enhance the company's investment value, the company has purchased a total of 1,575,800 shares of common stock as treasury shares from the Hong Kong Stock Exchange Limited from November 6, 2025 to the date of this announcement in accordance with the shareholders' approval and share repurchase authorization granted to the company's directors at the annual shareholders' meeting held on June 20, 2025. The shares repurchased accounted for approximately 0.69% of the total number of shares currently issued by the Company as of the date of this announcement. As of the date of this announcement, the total amount involved in the repurchase was approximately HK$31.16 million (excluding commissions and other expenses).

Zhitong Finance App News, Quanxin Bio-B (02509.HK) issued an announcement. The board of directors believes that the company's current stock price seriously underestimates the company's value. With full confidence in the company's future development prospects and high recognition of the company's intrinsic value, in order to continuously enhance market confidence in the company and enhance the company's investment value, the company has purchased a total of 1,575,800 shares of common stock as treasury shares from the Hong Kong Stock Exchange Limited from November 6, 2025 to the date of this announcement in accordance with the shareholders' approval and share repurchase authorization granted to the company's directors at the annual shareholders' meeting held on June 20, 2025. The shares repurchased accounted for approximately 0.69% of the total number of shares currently issued by the Company as of the date of this announcement. As of the date of this announcement, the total amount involved in the repurchase was approximately HK$31.16 million (excluding commissions and other expenses).